Thrombosis management

Thrombosis Risk

Prophylaxis of Thromboembolic Disease: A Multidisciplinary Discussion

Nov 7, 2008 11:46 EST

What are the barriers to identifying and effectively treating patients at risk for thromboembolic disease? Join our panel of thrombosis experts, Drs Goldhaber, Hylek, McKean, and John Fanikos as they discuss strategies for reducing this deadly occurrence.

Thrombosis Risk

The Prevention and Treatment of Thromboembolic Disease: A Cardiologist's Perspective

5 COMMENTS - Sep 22, 2008 16:00 EDT

Join Drs Harrington, Bode, Verheugt and Halperin as they discuss the spectrum of patients at risk for thrombotic events, strategies to prevent thrombosis on both sides of the circulation and recent clinical trial data which will impact patient care in the near future.

Thrombosis Risk

The search for the "ideal" anticoagulant: Where are we now?

6 COMMENTS - Jun 12, 2008 11:00 EDT

Join Drs Turpie, Kakkar, Eriksson and Lassen as they discuss the optimal targets for inhibition in the coagulation cascade and create a "wish list" of characteristics for the ideal oral anticoagulant: Is new clinical trial data realizing that wish?

Thrombosis Risk

Current and emerging therapies in the management of venothromboembolism

Dec 19, 2007 10:02 EST

On the RECORD: Join Drs Goldhaber, Turpie, Ansell and Kakkar as they discuss how new data from the RECORD 1, 2 and 3 studies on the use of oral factor Xa inhibitors will impact the prevention and treatment of venothromboembolism.

CME provider: Medscape.
Supported by an educational grant from Bayer HealthCare AG and from Ortho-McNeil, Inc, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc, administered by Ortho-McNeil-Janssen Scientific Affairs, LLC.

	True
	False